Bupivacaine inhibits thromboxane A2-induced vasoconstriction in rat thoracic aorta

Anesthesia and Analgesia

Volumn 99, Issue 1, 2004, Pages 97-102

  Hahnenkamp, Klaus ^a   Nollet, Joke ^b   Strümper, Danja ^a   Halene, Tobias ^a   Rathman, Pia ^a   Mortier, Eike ^b   Van Aken, Hugo ^a   Knapp, Joerg ^c   Durieux, Marcel E ^a,e   Hoenemann, Christian W ^d  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d Marienhospital Vechta   (Germany)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; BUPIVACAINE; LOCAL ANESTHETIC AGENT; THROMBOXANE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG INHIBITION; MEDIATOR RELEASE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; THROMBOCYTE AGGREGATION; UREA CYCLE; VASCULAR RING; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 20244375650     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000118107.62304.25     Document Type: Article

References (25)

1. Fitzgerald DJ, Doran J, Jackson E, FitzGerald GA. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo. J Clin Invest 1986;77: 496-502.
2. Yamamoto Y, Kamiya K, Terao S. Modeling of human thromboxane A2 receptor and analysis of the receptor-ligand interaction. J Med Chem 1993;36:820-5.
3. Kurosawa M. Role of thromboxane A2 synthetase inhibitors in the treatment of patients with bronchial asthma. Clin Ther 1995; 17:2-11.
4. Vesterqvist O, Schott U, Berseus O, et al. In vivo production of thromboxane and prostacyclin in patients following total hip arthroplasty. Scand J Clin Lab Invest 1988;48:233-9.
5. Teoh KH, Fremes SE, Weisel RD, et al. Cardiac release of prostacyclin and thromboxane A2 during coronary revascularization. J Thorac Cardiovasc Surg 1987;93:120-6.
6. Schilling MK, Gassmann N, Sigurdsson GH, et al. Role of thromboxane and leukotriene B4 in patients with acute respiratory distress syndrome after oesophagectomy. Br J Anaesth 1998;80:36-40.
7. Barry MC, Kelly CJ, Stokes K, et al. Glyceryl trinitrate prevents neutrophil activation but not thromboxane release following ischaemia- reperfusion injury. Br J Surg 1996;83:1095-100.
8. Ylikorkala O, Makila UM. Prostacyclin and thromboxane in gynecology and obstetrics. Am J Obstet Gynecol 1985;152: 318-29.
9. von Houwelingen AC, Thorngren M, Hornstra G, Born GV. Release of thromboxane A2 and beta-thromboglobulin during in-vivo plug formation following standardized skin incisions: effect of a moderate fish intake. Thromb Haemost 1992;67:713-7.
10. Rodgers A, Walker N, Schug S, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ 2000;321:1493.
11. Hahnenkamp K, Theilmeier G, Van Aken HK, Hoenemann CW. The effects of local anesthetics on perioperative coagulation, inflammation, and microcirculation. Anesth Analg 2002;94: 1441-7.
12. Honemann CW, Arledge JA, Podranski T, et al. Volatile and local anesthetics interfere with thromboxane A2 receptors recombinantly expressed in Xenopus oocytes. Adv Exp Med Biol 1999;469:277-83.
13. Lo B, Honemann CW, Kohrs R, et al. Local anesthetic actions on thromboxane-induced platelet aggregation. Anesth Analg 2001; 93:1240-5.
14. Knapp J, Boknik P, Linck B, et al. The effect of the protein phosphatases inhibitor cantharidin on beta-adrenoceptor-mediated vasorelaxation. Br J Pharmacol 1997;120:421-8.
15. Hirsh PD, Hillis LD, Campbell WB, et al. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med 1981;304:685-91.
16. Dom GW, Becker MW. Thromboxane A2 stimulated signal transduction in vascular smooth muscle. J Pharmacol Exp Ther 1993;265:447-56.
17. Rygnestad T, Zahlsen K, Bergslien O, Dale O. Focus on mobilisation after lower abdominal surgery: a double-blind randomised comparison of epidural bupivacaine with morphine vs. lidocaine with morphine for postoperative analgesia. Acta Anaesthesiol Scand 1999;43:380-7.
18. Ishiyama T, Dohi S, Iida H, Watanabe Y. The effects of topical and intravenous ropivacaine on canine pial microcirculation. Anesth Analg 1997;85:75-81.
19. Johns RA. Local anesthetics inhibit endothelium-dependent vasodilation. Anesthesiology 1989;70:805-11.
20. Turan NN, Tuncay DA, Celebi H. Effects of lidocaine on rabbit isolated thoracic aorta. Pharmacol Res 2000;42:453-8.
21. Struemper D, Durieux ME, Roekarts P. Endothelial and microvascular function. Semin Cardiothorac Vasc Anesth 2003;7: 225-38.
22. Fischer LG, Honemann CW, Patrie JT, et al. Ropivacaine attenuates pulmonary vasoconstriction induced by thromboxane A2 analogue in the isolated perfused rat lung. Reg Anesth Pain Med 2000;25:187-94.
23. Nietgen GW, Chan CK, Durieux ME. Inhibition of lysophosphatidate signaling by lidocaine and bupivacaine. Anesthesiology 1997;86:1112-9.
24. Hollmann MW, Wieczorek KS, Berger A, Durieux ME. Local anesthetic inhibition of G protein-coupled receptor signaling by interference with Galpha(q) protein function. Mol Pharmacol 2001;59:294-301.
25. He GW, Yang CQ. Inhibition of vasoconstriction by the thromboxane A2 antagonist GR32191B in the human radial artery. Br J Clin Pharmacol 1999;48:207-15.